The first antibody-drug conjugate targeting folate receptor <strong>α—</strong>mirvetuximab soravtansine

doi:10.3969/j.issn.1672-3384.2020.12.004

PDF(673 KB)

Clinical Medication Journal ›› 2020, Vol. 18 ›› Issue (12) : 17-22. DOI: 10.3969/j.issn.1672-3384.2020.12.004

Drugs in the Future

The first antibody-drug conjugate targeting folate receptor α—mirvetuximab soravtansine

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2020, 18(12): 17-22 https://doi.org/10.3969/j.issn.1672-3384.2020.12.004

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(673 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2020-10-21	2020-12-01
Issue Date
2020-12-01

Please choose a citation manager

Content to export